201 related articles for article (PubMed ID: 17214117)
1. Intensive lipid-lowering therapy: obvious benefits, possible risks.
Zimlichman E; Szyper-Kravitz M; Katz U; Shoenfeld Y
Isr Med Assoc J; 2006 Dec; 8(12):890-1. PubMed ID: 17214117
[No Abstract] [Full Text] [Related]
2. Lipid-lowering therapy--benefits and risks.
Abinader EG
Isr Med Assoc J; 2007 Feb; 9(2):132-3; author reply 133-4. PubMed ID: 17354321
[No Abstract] [Full Text] [Related]
3. Lipid-lowering therapy--benefits and risks.
Shechter M
Isr Med Assoc J; 2007 Feb; 9(2):133; author reply 133-4. PubMed ID: 17348492
[No Abstract] [Full Text] [Related]
4. Choice of lipid-regulating drugs.
Med Lett Drugs Ther; 2001 May; 43(1105):43-8. PubMed ID: 11378632
[No Abstract] [Full Text] [Related]
5. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
[No Abstract] [Full Text] [Related]
6. [Antilipemic therapy and rhabdomyolysis].
Paragh G; Balogh Z; Romics L
Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin + ezetimibe: a combination with no proven advantages.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
[No Abstract] [Full Text] [Related]
8. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
9. Fatal rhabdomyolysis caused by lipid-lowering therapy.
Federman DG; Hussain F; Walters AB
South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
[TBL] [Abstract][Full Text] [Related]
10. Fenofibric Acid (trilipix).
Med Lett Drugs Ther; 2009 May; 51(1311):33-4. PubMed ID: 19417718
[No Abstract] [Full Text] [Related]
11. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
Kashani A; Sallam T; Bheemreddy S; Mann DL; Wang Y; Foody JM
Am J Cardiol; 2008 Jun; 101(11):1606-13. PubMed ID: 18489938
[TBL] [Abstract][Full Text] [Related]
12. Experts confirm statins' safety but advise caution with certain patients.
Levenson D
Rep Med Guidel Outcomes Res; 2002 Jul; 13(13):1-2, 5. PubMed ID: 12515256
[No Abstract] [Full Text] [Related]
13. [Lipid control in the double pack. Combined drugs to achieve the goal].
MMW Fortschr Med; 2002 Jun; 144(23):53. PubMed ID: 12119910
[No Abstract] [Full Text] [Related]
14. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
15. Ask the doctor. I have tried all of the statin drugs to lower my cholesterol, but each one has caused severe muscle pain. Are there any non-statin medications I could try using to lower my cholesterol?
Lee T
Harv Heart Lett; 2010 Aug; 20(12):8. PubMed ID: 20812395
[No Abstract] [Full Text] [Related]
16. [Ezetimibe: caution in the face of doubt].
Araujo F; Mateo de Castro J; Encinas Barrios C
Farm Hosp; 2010; 34(4):212-4. PubMed ID: 20153227
[No Abstract] [Full Text] [Related]
17. Rosuvastatin--a new lipid-lowering drug.
Med Lett Drugs Ther; 2003 Oct; 45(1167):81-3. PubMed ID: 14534507
[No Abstract] [Full Text] [Related]
18. [Hydroxymethylglutaryl coenzyme A reductase inhibitors].
Schuff-Werner P
Internist (Berl); 1994 Mar; 35(3):288-94; discussion 295. PubMed ID: 8175295
[No Abstract] [Full Text] [Related]
19. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
[TBL] [Abstract][Full Text] [Related]
20. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.
Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K
Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
